OBJECT: Quality improvement techniques are being implemented in many areas of medicine. In an effort to reduce the ventriculoperitoneal shunt infection rate, a standardized protocol was developed and implemented at 4 centers of the Hydrocephalus Clinical Research Network (HCRN). METHODS: The protocol was developed sequentially by HCRN members using the current literature and prior institutional experience until consensus was obtained. The protocol was prospectively applied at each HCRN center to all children undergoing a shunt insertion or revision procedure. Infections were defined on the basis of CSF, wound, or pseudocyst cultures; wound breakdown; abdominal pseudocyst; or positive blood cultures in the presence of a ventriculoatrial shunt. Procedures and infections were measured before and after protocol implementation. RESULTS: Twenty-one surgeons at 4 centers performed 1571 procedures between June 1, 2007, and February 28, 2009. The minimum follow-up was 6 months. The Network infection rate decreased from 8.8% prior to the protocol to 5.7% while using the protocol (p = 0.0028, absolute risk reduction 3.15%, relative risk reduction 36%). Three of 4 centers lowered their infection rate. Shunt surgery after external ventricular drainage (with or without prior infection) had the highest infection rate. Overall protocol compliance was 74.5% and improved over the course of the observation period. Based on logistic regression analysis, the use of BioGlide catheters (odds ratio [OR] 1.91, 95% CI 1.19-3.05; p = 0.007) and the use of antiseptic cream by any members of the surgical team (instead of a formal surgical scrub by all members of the surgical team; OR 4.53, 95% CI 1.43-14.41; p = 0.01) were associated with an increased risk of infection. CONCLUSIONS: The standardized protocol for shunt surgery significantly reduced shunt infection across the HCRN. Overall protocol compliance was good. The protocol has established a common baseline within the Network, which will facilitate assessment of new treatments. Identification of factors associated with infection will allow further protocol refinement in the future.
OBJECT: Quality improvement techniques are being implemented in many areas of medicine. In an effort to reduce the ventriculoperitoneal shunt infection rate, a standardized protocol was developed and implemented at 4 centers of the Hydrocephalus Clinical Research Network (HCRN). METHODS: The protocol was developed sequentially by HCRN members using the current literature and prior institutional experience until consensus was obtained. The protocol was prospectively applied at each HCRN center to all children undergoing a shunt insertion or revision procedure. Infections were defined on the basis of CSF, wound, or pseudocyst cultures; wound breakdown; abdominal pseudocyst; or positive blood cultures in the presence of a ventriculoatrial shunt. Procedures and infections were measured before and after protocol implementation. RESULTS: Twenty-one surgeons at 4 centers performed 1571 procedures between June 1, 2007, and February 28, 2009. The minimum follow-up was 6 months. The Network infection rate decreased from 8.8% prior to the protocol to 5.7% while using the protocol (p = 0.0028, absolute risk reduction 3.15%, relative risk reduction 36%). Three of 4 centers lowered their infection rate. Shunt surgery after external ventricular drainage (with or without prior infection) had the highest infection rate. Overall protocol compliance was 74.5% and improved over the course of the observation period. Based on logistic regression analysis, the use of BioGlide catheters (odds ratio [OR] 1.91, 95% CI 1.19-3.05; p = 0.007) and the use of antiseptic cream by any members of the surgical team (instead of a formal surgical scrub by all members of the surgical team; OR 4.53, 95% CI 1.43-14.41; p = 0.01) were associated with an increased risk of infection. CONCLUSIONS: The standardized protocol for shunt surgery significantly reduced shunt infection across the HCRN. Overall protocol compliance was good. The protocol has established a common baseline within the Network, which will facilitate assessment of new treatments. Identification of factors associated with infection will allow further protocol refinement in the future.
Authors: John R W Kestle; Hugh J L Garton; William E Whitehead; James M Drake; Abhaya V Kulkarni; D Douglas Cochrane; Cheryl Muszynski; Marion L Walker Journal: J Neurosurg Date: 2006-09 Impact factor: 5.115
Authors: Marlene R Miller; Michael Griswold; J Mitchell Harris; Gayane Yenokyan; W Charles Huskins; Michele Moss; Tom B Rice; Debra Ridling; Deborah Campbell; Peter Margolis; Stephen Muething; Richard J Brilli Journal: Pediatrics Date: 2010-01-11 Impact factor: 7.124
Authors: J Kestle; J Drake; R Milner; C Sainte-Rose; G Cinalli; F Boop; J Piatt; S Haines; S Schiff; D Cochrane; P Steinbok; N MacNeil Journal: Pediatr Neurosurg Date: 2000-11 Impact factor: 1.162
Authors: John R W Kestle; James M Drake; D Douglas Cochrane; Ruth Milner; Marion L Walker; Rick Abbott; Frederick A Boop Journal: J Neurosurg Date: 2003-02 Impact factor: 5.115
Authors: Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell Journal: J Pediatric Infect Dis Soc Date: 2013-08-26 Impact factor: 3.164
Authors: Nehaw Sarmey; Varun R Kshettry; Michael F Shriver; Ghaith Habboub; Andre G Machado; Robert J Weil Journal: Childs Nerv Syst Date: 2015-02-17 Impact factor: 1.475
Authors: Brian W Hanak; Chia-Yun Hsieh; William Donaldson; Samuel R Browd; Kenneth K S Lau; William Shain Journal: J Biomed Mater Res B Appl Biomater Date: 2017-06-20 Impact factor: 3.368
Authors: Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle Journal: J Neurosurg Pediatr Date: 2018-02-02 Impact factor: 2.375
Authors: Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano Journal: J Neurosurg Date: 2018-08-03 Impact factor: 5.115
Authors: Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett Journal: J Pediatr Date: 2016-09-28 Impact factor: 4.406